Emil Hartela Investing

Haypp Watch: Q4 Delivered; Real Growth Confirmed

US momentum accelerating; margins secondary to scale

Feb 13 • Emil

6

Execution Memo No. 11 (New position)

Capital Back at Work; Building the 2026 Book

Feb 10 • Emil

January 2026

Haypp Watch: Q4 Revenue Prediction

2025 Q4; Prediction Engine Upgrade and Early Signs of Real Growth

Jan 7 • Emil

5

November 2025

Execution Memo No. 10 (Tempus update)

TechBio Carnage: Not the Time to Panic, Time to Capitalize

Nov 7, 2025 • Emil

2

Haypp Group Q3 (Long Update)

Feeling Bullish. 2026 is Haypp’s Year.

Nov 7, 2025 • Emil

4

Execution Memo No. 9

Haypp, Tempus, and TPB face their moment of truth

Nov 6, 2025 • Emil

2

October 2025

Haypp Group Q3 Earnings Preview

Weak summer months aside, all signals point to record volumes

Oct 31, 2025 • Emil

4

Execution Memo No. 8

A rapid-fire portfolio rundown and the next moves in motion.

Oct 24, 2025 • Emil

HAYPP Watch: September 2025 & Q3

Haypp looks set for its best quarter ever; I’ll share my Q3 forecast in this report.

Oct 9, 2025 • Emil

3

Execution Memo No. 007

Turning Point Brands: From Vision to Results

Oct 7, 2025 • Emil

2

Execution Memo No. 006

Position updates, portfolio shifts, and a 45% gain in under 24 hours

Oct 2, 2025 • Emil

1

September 2025

Execution Memo No. 005

123% YTD; Extreme Volatility; Biotech Takes the Lead 24.09.2025

Sep 24, 2025 • Emil

1